We are live on
!
Find out more
Immunic
IMUX
IMUX
54 hedge funds and large institutions have $2.39M invested in Immunic in 2018 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 20 increasing their positions, 7 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
186% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 7
0.03% less ownership
Funds ownership: 0.08% → 0.05% (-0.03%)
13% less funds holding
Funds holding: 62 → 54 (-8)
35% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 23
88% less call options, than puts
Call options by funds: $76K | Put options by funds: $659K
97% less capital invested
Capital invested by funds: $95M → $2.39M (-$92.6M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
54
Holders Change
-8
Holders Change %
-12.9%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
15
Increased
20
Reduced
7
Closed
23
Calls
$76K
Puts
$659K
Net Calls
-$583K
Net Calls Change
+$1.95M
Top Buyers
| 1 |
Millennium Management
New York
|
+$5.12M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.16M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$2.15M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$1.7M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.51M |
Top Sellers
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$21.1M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$7.5M |
| 3 |
AG
Artal Group
Luxembourg
|
-$6.85M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.59M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.24M |
